Search PDMR transactions

Notifier
Name of person with notification obligation
Henrik Bergentoft
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Henrik Bergentoft
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Oncopeptides AB BTA SE0027999608 Subscription 14,258 Quantity 1.55 SEK 16/03/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB BTA SE0027999608 Subscription 16/03/2026 NASDAQ STOCKHOLM AB 14,258 (Quantity) 1.55 SEK
Total: 14,258
<< Back